Life Sciences

Oct 19, 2026

NTL HEALTHCARE Presents CerviCARE AI in South Africa

NTL HEALTHCARE presented its cervical screening system at WHX Johannesburg and held discussions about adoption in South Africa.

Oct 19, 2026

Ultima Genomics to Sequence 80,000 Samples for UK Biobank Immune Study

Ultima Genomics will provide its UG200 sequencing platform for a study that will create an AI foundation dataset from 80,000 UK Biobank blood samples.

Oct 19, 2026

GPT-5 Missed 27.5% of Confirmed Pediatric Growth Plate Fractures

GPT-5 failed to identify 221 of 805 confirmed pediatric growth plate fractures in a study of anonymized X rays.

Oct 19, 2026

HistoIndex and A*STAR Partner on Fibrosis Drug Evaluation

HistoIndex and A*STAR will use quantitative tissue analysis to evaluate therapeutic candidates for fibrotic diseases during preclinical research.

Oct 18, 2026

STPI Hosts AI Healthcare Conclave at IIT BHU

Software Technology Parks of India and IIT BHU's entrepreneurship center held a conclave in Varanasi focused on AI applications in healthcare and assistive technology.

Oct 17, 2026

Masimo Gets FDA Clearance for AFib Detection on Radius VSM

Masimo received FDA 510(k) clearance for an atrial fibrillation detection feature on its Radius VSM patient monitor. The feature continuously analyzes pulse waveform data and identifies rhythms that may require further evaluation.

Oct 16, 2026

Attilio appoints Buck Institute CEO Eric Verdin as cochairman

Longevity platform Attilio appoints Buck Institute President and CEO Eric Verdin as cochairman to guide its scientific direction and member assessments.

Oct 16, 2026

Specialty1 Partners Invests in AI for Dental Practice Operations

Specialty1 Partners is investing in AI tools for clinical documentation, patient communication, insurance administration and business operations across its dental practice network.

Oct 15, 2026

Study Tracks 270 Million Clinical AI Queries on OpenEvidence

Researchers analyzed how 950,000 US clinicians used OpenEvidence from January 2024 to June 2026. Most queries concerned clinical decisions, particularly treatment and patient management.

Oct 15, 2026

UK Medicines Regulator Plans AI Safety Tools by 2030

The MHRA plans to use AI to detect medicine safety signals earlier, improve clinical trial applications and clarify rules for AI medical products.

Oct 15, 2026

Reveleer names Jean-Luc Neptune chief medical officer

Jean Luc Neptune will lead clinical strategy across Reveleer's risk adjustment, quality and member management programs, which serve 12 million covered lives.

Oct 15, 2026

Tucuvi Joins Microsoft Pegasus Program

Tucuvi joins the Microsoft for Startups Pegasus Program to expand access to its clinical voice AI platform across health systems.

Oct 15, 2026

Zealand Pharma signs AI obesity drug deal worth up to $1.2 billion

Zealand Pharma will use Generate:Biomedicines' generative AI platform to develop protein treatments for obesity and metabolic diseases under a deal worth up to $1.2 billion.

Oct 15, 2026

Benchling Launches Science Foundries for Biotech R&D

Science Foundries coordinates AI agents, scientific models, lab instruments, research partners and scientists across biotech research workflows.

Oct 15, 2026

Waterdrop Says AI Cut Complex Underwriting Time by 80% in 2025

Waterdrop's 2025 ESG report says its KEYI.AI underwriting system reduced processing time for complex health insurance cases by 80% and achieved 99.8% accuracy.

Oct 15, 2026

PointClickCare Adds Former Appen CEO Armughan Ahmad to Board

PointClickCare appointed former Appen CEO Armughan Ahmad to its board of directors to support its healthcare AI strategy.

Oct 15, 2026

Sunbound Acquires Richter and Raises $24 Million

Sunbound acquired Richter Healthcare Consultants and closed a $24 million Series A round led by TTV Capital. The deal adds revenue cycle, accounting and consulting services for senior care operators to Sunbound's software platform.

Oct 15, 2026

SciBase Secures First US Insurance Coverage for Nevisense

SciBase secured its first medical policy from a private US insurer covering the use of Nevisense to assess certain suspicious skin lesions.

Oct 15, 2026

SimBioSys Gets FDA Clearance for AI Breast Cancer Recurrence Tool

TumorSight Risk analyzes breast MRI, pathology and clinical data to estimate recurrence risk at five and ten years for certain patients with early stage breast cancer.

Oct 15, 2026

Nabla Integrates OpenEvidence Into Clinical AI Assistant

Nabla now lets clinicians access OpenEvidence and ask patient specific clinical questions alongside their notes.